» Articles » PMID: 10973241

Domain-specific Mutations in TGFB1 Result in Camurati-Engelmann Disease

Overview
Journal Nat Genet
Specialty Genetics
Date 2000 Sep 6
PMID 10973241
Citations 94
Authors
Affiliations
Soon will be listed here.
Abstract

Camurati-Engelmann disease (CED, MIM 131300) is an autosomal dominant, progressive diaphyseal dysplasia characterized by hyperosteosis and sclerosis of the diaphyses of long bones. We recently assigned the CED locus to an interval between D19S422 and D19S606 at chromosome 19q13.1-q13.3, which two other groups confirmed. As the human transforming growth factor-1 gene (TGFB1) is located within this interval, we considered it a candidate gene for CED.

Citing Articles

Legumain is a paracrine regulator of osteoblast differentiation and mediates the inhibitory effect of TGF-β1 on osteoblast maturation.

Forbord K, Lunde N, Bosnjak-Olsen T, Johansen H, Solberg R, Jafari A Front Endocrinol (Lausanne). 2024; 15:1445049.

PMID: 39363898 PMC: 11446771. DOI: 10.3389/fendo.2024.1445049.


Heterozygous mutations in the straitjacket region of the latency-associated peptide domain of TGFB2 cause Camurati-Engelmann disease type II.

Wang Z, Kometani M, Zeitlin L, Wilnai Y, Kinoshita A, Yoshiura K J Hum Genet. 2024; 69(11):599-605.

PMID: 39014191 DOI: 10.1038/s10038-024-01274-1.


Aging impairs the osteocytic regulation of collagen integrity and bone quality.

Schurman C, Kaya S, Dole N, Luna N, Castillo N, Potter R Bone Res. 2024; 12(1):13.

PMID: 38409111 PMC: 10897167. DOI: 10.1038/s41413-023-00303-7.


The roles and regulatory mechanisms of TGF-β and BMP signaling in bone and cartilage development, homeostasis and disease.

Wu M, Wu S, Chen W, Li Y Cell Res. 2024; 34(2):101-123.

PMID: 38267638 PMC: 10837209. DOI: 10.1038/s41422-023-00918-9.


TGF-β signaling in health and disease.

Massague J, Sheppard D Cell. 2023; 186(19):4007-4037.

PMID: 37714133 PMC: 10772989. DOI: 10.1016/j.cell.2023.07.036.